HomeELOX • OTCMKTS
add
Eloxx Pharmaceuticals Inc
Previous close
$0.16
Day range
$0.070 - $0.25
Market cap
912.95K USD
Avg Volume
9.08K
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 6.44M | -27.06% |
Net income | -6.00M | -90.74% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -6.40M | -163.17% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 4.78M | 4,210.81% |
Total assets | 5.27M | 77.08% |
Total liabilities | 17.18M | -37.11% |
Total equity | -11.91M | — |
Shares outstanding | 5.07M | — |
Price to book | -0.06 | — |
Return on assets | -97.59% | — |
Return on capital | 226.12% | — |
Cash Flow
Net change in cash
| (USD) | 2025info | Y/Y change |
|---|---|---|
Net income | -6.00M | -90.74% |
Cash from operations | -6.33M | -34.19% |
Cash from investing | 1.00K | -97.37% |
Cash from financing | 11.00M | 219.89% |
Net change in cash | 4.68M | 477.63% |
Free cash flow | -4.90M | -41.26% |
About
Founded
1999
Headquarters
Website
Employees
10
